+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Fluid Biopsy Market 2022-2026

  • ID: 5504423
  • Report
  • April 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AccuraGen Holdings
  • Bio Rad Laboratories Inc.
  • CellMax Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • MDNA Lfe Sciences Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the liquid biopsy market and it is poised to grow by $1.74 bn during 2022-2026, accelerating at a CAGR of 18.77% during the forecast period. The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer, growing focus on personalized medicine for cancer care, and increasing focus on early detection of cancer.

The liquid biopsy market analysis includes the technology segment and geographic landscape.

The liquid biopsy market is segmented as below:

By Technology

  • CTC and ctDNA
  • exosome and RNA

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing funding/investment for fluid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships and M&A and emerging applications of fluid biopsy will lead to sizable demand in the market.

The report on liquid biopsy market covers the following areas:

  • Liquid biopsy market sizing
  • Liquid biopsy market forecast
  • Liquid biopsy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include AccuraGen Holdings, Adaptive Biotechnologies Corp., ANGLE Plc, Bio Rad Laboratories Inc., Biocept Inc., CellMax Inc., Epigenomics AG, F. Hoffmann La Roche Ltd., GeneFirst Ltd., Guardant Health Inc., HansaBioMed Life Sciences Ltd., Illumina Inc., MDNA Lfe Sciences Inc., MDxHealth Group, NeoGenomics Laboratories Inc., QIAGEN NV, Rarecells Inc., SAGA Diagnostics AB, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AccuraGen Holdings
  • Bio Rad Laboratories Inc.
  • CellMax Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • MDNA Lfe Sciences Inc.

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Technology
5.1 Market segments
Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
5.2 Comparison by Technology
Exhibit 26: Chart on Comparison by Technology
Exhibit 27: Data Table on Comparison by Technology
5.3 CTC and ctDNA - Market size and forecast 2021-2026
Exhibit 28: Chart on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
5.4 Exosome and RNA - Market size and forecast 2021-2026
Exhibit 32: Chart on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Exosome and RNA - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Exosome and RNA - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Technology
Exhibit 36: Market opportunity by Technology ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Bio Rad Laboratories Inc.
Exhibit 85: Bio Rad Laboratories Inc. - Overview
Exhibit 86: Bio Rad Laboratories Inc. - Business segments
Exhibit 87: Bio Rad Laboratories Inc. - Key news
Exhibit 88: Bio Rad Laboratories Inc. - Key offerings
Exhibit 89: Bio Rad Laboratories Inc. - Segment focus
10.4 F. Hoffmann La Roche Ltd.
Exhibit 90: F. Hoffmann La Roche Ltd. - Overview
Exhibit 91: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 92: F. Hoffmann La Roche Ltd. - Key news
Exhibit 93: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 94: F. Hoffmann La Roche Ltd. - Segment focus
10.5 GeneFirst Ltd.
Exhibit 95: GeneFirst Ltd. - Overview
Exhibit 96: GeneFirst Ltd. - Product / Service
Exhibit 97: GeneFirst Ltd. - Key offerings
10.6 Guardant Health Inc.
Exhibit 98: Guardant Health Inc. - Overview
Exhibit 99: Guardant Health Inc. - Product / Service
Exhibit 100: Guardant Health Inc. - Key news
Exhibit 101: Guardant Health Inc. - Key offerings
10.7 HansaBioMed Life Sciences Ltd.
Exhibit 102: HansaBioMed Life Sciences Ltd. - Overview
Exhibit 103: HansaBioMed Life Sciences Ltd. - Product / Service
Exhibit 104: HansaBioMed Life Sciences Ltd. - Key offerings
10.8 Illumina Inc.
Exhibit 105: Illumina Inc. - Overview
Exhibit 106: Illumina Inc. - Business segments
Exhibit 107: Illumina Inc. - Key news
Exhibit 108: Illumina Inc. - Key offerings
Exhibit 109: Illumina Inc. - Segment focus
10.9 MDxHealth Group
Exhibit 110: MDxHealth Group - Overview
Exhibit 111: MDxHealth Group - Business segments
Exhibit 112: MDxHealth Group - Key offerings
Exhibit 113: MDxHealth Group - Segment focus
10.10 QIAGEN NV
Exhibit 114: QIAGEN NV - Overview
Exhibit 115: QIAGEN NV - Product / Service
Exhibit 116: QIAGEN NV - Key news
Exhibit 117: QIAGEN NV - Key offerings
10.11 Rarecells Inc.
Exhibit 118: Rarecells Inc. - Overview
Exhibit 119: Rarecells Inc. - Product / Service
Exhibit 120: Rarecells Inc. - Key offerings
10.12 Siemens Healthcare GmbH
Exhibit 121: Siemens Healthcare GmbH - Overview
Exhibit 122: Siemens Healthcare GmbH - Business segments
Exhibit 123: Siemens Healthcare GmbH - Key news
Exhibit 124: Siemens Healthcare GmbH - Key offerings
Exhibit 125: Siemens Healthcare GmbH - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Technology - Market share 2021-2026 (%)
Exhibits 25: Data Table on Technology - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Technology
Exhibits 27: Data Table on Comparison by Technology
Exhibits 28: Chart on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on CTC and ctDNA - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on CTC and ctDNA - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Exosome and RNA - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Exosome and RNA - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Exosome and RNA - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Technology ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share by geography 2021-2026 (%)
Exhibits 39: Data Table on Market share by geography 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity by geography ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Bio Rad Laboratories Inc. - Overview
Exhibits 86: Bio Rad Laboratories Inc. - Business segments
Exhibits 87: Bio Rad Laboratories Inc. - Key news
Exhibits 88: Bio Rad Laboratories Inc. - Key offerings
Exhibits 89: Bio Rad Laboratories Inc. - Segment focus
Exhibits 90: F. Hoffmann La Roche Ltd. - Overview
Exhibits 91: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 92: F. Hoffmann La Roche Ltd. - Key news
Exhibits 93: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 94: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 95: GeneFirst Ltd. - Overview
Exhibits 96: GeneFirst Ltd. - Product / Service
Exhibits 97: GeneFirst Ltd. - Key offerings
Exhibits 98: Guardant Health Inc. - Overview
Exhibits 99: Guardant Health Inc. - Product / Service
Exhibits 100: Guardant Health Inc. - Key news
Exhibits 101: Guardant Health Inc. - Key offerings
Exhibits 102: HansaBioMed Life Sciences Ltd. - Overview
Exhibits 103: HansaBioMed Life Sciences Ltd. - Product / Service
Exhibits 104: HansaBioMed Life Sciences Ltd. - Key offerings
Exhibits 105: Illumina Inc. - Overview
Exhibits 106: Illumina Inc. - Business segments
Exhibits 107: Illumina Inc. - Key news
Exhibits 108: Illumina Inc. - Key offerings
Exhibits 109: Illumina Inc. - Segment focus
Exhibits 110: MDxHealth Group - Overview
Exhibits 111: MDxHealth Group - Business segments
Exhibits 112: MDxHealth Group - Key offerings
Exhibits 113: MDxHealth Group - Segment focus
Exhibits 114: QIAGEN NV - Overview
Exhibits 115: QIAGEN NV - Product / Service
Exhibits 116: QIAGEN NV - Key news
Exhibits 117: QIAGEN NV - Key offerings
Exhibits 118: Rarecells Inc. - Overview
Exhibits 119: Rarecells Inc. - Product / Service
Exhibits 120: Rarecells Inc. - Key offerings
Exhibits 121: Siemens Healthcare GmbH - Overview
Exhibits 122: Siemens Healthcare GmbH - Business segments
Exhibits 123: Siemens Healthcare GmbH - Key news
Exhibits 124: Siemens Healthcare GmbH - Key offerings
Exhibits 125: Siemens Healthcare GmbH - Segment focus
Exhibits 126: Inclusions checklist
Exhibits 127: Exclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AccuraGen Holdings
  • Bio Rad Laboratories Inc.
  • CellMax Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • MDNA Lfe Sciences Inc.
The publisher recognizes the following companies as the key players in the global liquid biopsy market: AccuraGen Holdings, Adaptive Biotechnologies Corp., ANGLE Plc, Bio Rad Laboratories Inc., Biocept Inc., CellMax Inc., Epigenomics AG, F. Hoffmann La Roche Ltd., GeneFirst Ltd., Guardant Health Inc., HansaBioMed Life Sciences Ltd., Illumina Inc., MDNA Lfe Sciences Inc., MDxHealth Group, NeoGenomics Laboratories Inc., QIAGEN NV, Rarecells Inc., SAGA Diagnostics AB, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing funding/investment for fluid biopsy.`

According to the report, one of the major drivers for this market is the increasing incidence of cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AccuraGen Holdings
  • Adaptive Biotechnologies Corp.
  • ANGLE Plc
  • Bio Rad Laboratories Inc.
  • Biocept Inc.
  • CellMax Inc.
  • Epigenomics AG
  • F. Hoffmann La Roche Ltd.
  • GeneFirst Ltd.
  • Guardant Health Inc.
  • HansaBioMed Life Sciences Ltd.
  • Illumina Inc.
  • MDNA Lfe Sciences Inc.
  • MDxHealth Group
  • NeoGenomics Laboratories Inc.
  • QIAGEN NV
  • Rarecells Inc.
  • SAGA Diagnostics AB
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown